Sonoma Pharmaceuticals, Inc. (SNOA) › Net IncomeSonoma Pharmaceuticals, Inc. (SNOA) — Net IncomeAnnual figures by fiscal year, from SEC filings.2011: -$7.95M2012: -$7.33M2013: -$5.43M2014: $3.73M2015: -$8.20M2016: -$10.16M2017: $9.27M2018: -$14.33M2019: -$11.80M2020: -$3.31M2021: -$3.95M2022: -$5.09M2023: -$5.15M2024: -$4.83M2025: -$3.46M2026: -$3.17M-$3.17M2011Net Income (USD)2026Fiscal YearNet IncomeChange YoY2026-$3.17M+8.2%2025-$3.46M+28.5%2024-$4.83M+6.1%2023-$5.15M-1.3%2022-$5.09M-28.8%2021-$3.95M-19.4%2020-$3.31M+72.0%2019-$11.80M+17.7%2018-$14.33M-254.5%2017$9.27M+191.3%2016-$10.16M-23.9%2015-$8.20M-319.6%2014$3.73M+168.8%2013-$5.43M+25.9%2012-$7.33M+7.8%2011-$7.95M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share